• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童第二代抗精神病药物:风险和监测需求。

Second-generation antipsychotics in children: Risks and monitoring needs.

出版信息

Can Fam Physician. 2018 Sep;64(9):660-662.

PMID:30209096
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6135131/
Abstract

A 10-year-old male patient presented to my clinic with irritability associated with autism spectrum disorder, and previous therapeutic efforts had not been successful. Treatment with quetiapine has considerably reduced irritability and improved his quality of life; however, the patient's mother has stated that her child's clothes are no longer fitting because his waist size has increased substantially, and that he has gained 5 kg since treatment initiation 8 weeks ago. Should second-generation antipsychotic (SGA) treatment be stopped or continued, and how can these side effects be best mitigated in a family practice setting? Use of SGAs in pediatric patients has increased in recent years, which has brought to light a number of worrisome metabolic side effects that occur in children. Owing to the efficacy of treatment, SGAs must often be continued despite side effects. Even if the drug has been prescribed elsewhere, family physicians should closely monitor these patients following the Canadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics in Children guidelines. When starting an SGA, patients and their families should be educated on the importance of healthy eating and physical activity to preemptively mitigate potential side effects. Recent studies have also shown adjunctive metformin to have a potential role in reducing weight gain.

摘要

一位 10 岁男性患者因自闭症谱系障碍伴发的烦躁不安就诊于我的诊所,先前的治疗尝试均未成功。喹硫平治疗显著减轻了他的烦躁不安症状,提高了他的生活质量;然而,患儿的母亲表示,孩子的衣服不再合身,因为他的腰围明显增大,且自 8 周前开始治疗以来体重增加了 5 公斤。是否应该停止或继续第二代抗精神病药物(SGA)治疗,在家庭医疗环境中如何最好地减轻这些副作用?近年来,儿科患者中 SGA 的使用有所增加,这凸显了儿童中出现的一些令人担忧的代谢副作用。由于治疗效果,尽管存在副作用,SGAs 通常仍需继续使用。即使药物是在其他地方开的处方,家庭医生也应根据加拿大儿童抗精神病药监测有效性和安全性联盟的指南密切监测这些患者。开始使用 SGA 时,应向患者及其家属教育健康饮食和身体活动的重要性,以预先减轻潜在的副作用。最近的研究还表明,二甲双胍辅助治疗可能在减轻体重增加方面具有一定作用。

相似文献

1
Second-generation antipsychotics in children: Risks and monitoring needs.儿童第二代抗精神病药物:风险和监测需求。
Can Fam Physician. 2018 Sep;64(9):660-662.
2
Patient, Treatment, and Health Care Utilization Variables Associated with Adherence to Metabolic Monitoring Practices in Children and Adolescents Taking Second-Generation Antipsychotics.与接受第二代抗精神病药物治疗的儿童和青少年的代谢监测实践依从性相关的患者、治疗和医疗保健利用变量。
Can J Psychiatry. 2018 Apr;63(4):240-249. doi: 10.1177/0706743717751693. Epub 2018 Mar 11.
3
Treatment-related weight gain and metabolic complications in children with mental health disorders: potential role for lifestyle interventions.患有精神健康障碍儿童的治疗相关体重增加及代谢并发症:生活方式干预的潜在作用
Appl Physiol Nutr Metab. 2021 Mar;46(3):193-204. doi: 10.1139/apnm-2020-0259. Epub 2020 Nov 23.
4
Metabolic Monitoring of Child and Adolescent Patients on Atypical Antipsychotics by Psychiatrists and Primary Care Providers.精神科医生和初级保健提供者对使用非典型抗精神病药物的儿童和青少年患者进行代谢监测。
Am J Ther. 2020 Sep/Oct;27(5):e425-e430. doi: 10.1097/MJT.0000000000000853.
5
The effect of a computerized best practice alert system in an outpatient setting on metabolic monitoring in patients on second-generation antipsychotics.在门诊环境中,计算机化最佳实践警报系统对第二代抗精神病药物治疗患者代谢监测的影响。
J Clin Pharm Ther. 2020 Dec;45(6):1398-1404. doi: 10.1111/jcpt.13236. Epub 2020 Aug 7.
6
Metabolic side effects and pharmacogenetics of second-generation antipsychotics in children.第二代抗精神病药物在儿童中的代谢副作用及药物遗传学
Pharmacogenomics. 2015;16(9):981-96. doi: 10.2217/pgs.15.55. Epub 2015 Jun 24.
7
Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents.识别和监测儿童及青少年使用第二代抗精神病药物的不良事件。
Child Adolesc Psychiatr Clin N Am. 2006 Jan;15(1):177-206. doi: 10.1016/j.chc.2005.08.007.
8
Enhancing metabolic monitoring for children and adolescents using second-generation antipsychotics.使用第二代抗精神病药物增强儿童和青少年的代谢监测。
Int J Ment Health Nurs. 2018 Jun;27(3):1188-1198. doi: 10.1111/inm.12417. Epub 2017 Dec 4.
9
Safety considerations of the use of second generation antipsychotics in the treatment of major depression: extrapyramidal and metabolic side effects.第二代抗精神病药物用于治疗重度抑郁症的安全性考量:锥体外系及代谢副作用
Curr Drug Saf. 2010 Jul 2;5(3):263-6. doi: 10.2174/157488610791698325.
10
Evaluation of a computer-based intervention to enhance metabolic monitoring in psychiatry inpatients treated with second-generation antipsychotics.评估一种基于计算机的干预措施,以加强接受第二代抗精神病药物治疗的精神科住院患者的代谢监测。
J Clin Pharm Ther. 2012 Dec;37(6):668-73. doi: 10.1111/j.1365-2710.2012.01369.x. Epub 2012 Jul 30.

引用本文的文献

1
Cardiometabolic monitoring in children and adolescents prescribed antipsychotics in Australian primary care, 2011 to 2017.2011年至2017年澳大利亚初级保健机构中接受抗精神病药物治疗的儿童和青少年的心脏代谢监测
Aust N Z J Psychiatry. 2025 Aug 13;59(9):48674251361696. doi: 10.1177/00048674251361696.
2
Long-Term Metabolic Monitoring of Youths Treated with Second-Generation Antipsychotics 5 Years after Publication of the CAMESA Guidelines Are We Making Progress? Surveillance Métabolique à Long Terme des Jeunes Traités par Antipsychotiques de Deuxième Génération, Cinq ans Après la publication des Lignes Directrices Camesa: Faisons-Nous des Progrès?长效代谢监测:第二代抗精神病药物治疗青少年 5 年后——CAMESA 指南发布 5 年后:我们是否取得进展?
Can J Psychiatry. 2021 Jul;66(7):645-656. doi: 10.1177/0706743720974847. Epub 2020 Nov 26.

本文引用的文献

1
Patient, Treatment, and Health Care Utilization Variables Associated with Adherence to Metabolic Monitoring Practices in Children and Adolescents Taking Second-Generation Antipsychotics.与接受第二代抗精神病药物治疗的儿童和青少年的代谢监测实践依从性相关的患者、治疗和医疗保健利用变量。
Can J Psychiatry. 2018 Apr;63(4):240-249. doi: 10.1177/0706743717751693. Epub 2018 Mar 11.
2
Antipsychotic Prescribing and Safety Monitoring Practices in Children and Youth: A Population-Based Study in Alberta, Canada.抗精神病药物在儿童和青少年中的处方和安全性监测实践:加拿大艾伯塔省的一项基于人群的研究。
Clin Drug Investig. 2018 May;38(5):449-455. doi: 10.1007/s40261-018-0626-4.
3
Development of Metabolic Syndrome in Drug-Naive Adolescents After 12 Months of Second-Generation Antipsychotic Treatment.第二代抗精神病药物治疗12个月后初治青少年代谢综合征的发生情况
J Child Adolesc Psychopharmacol. 2017 Dec;27(10):884-891. doi: 10.1089/cap.2016.0171. Epub 2017 Aug 7.
4
Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People With Autism Spectrum Disorder: A Randomized Clinical Trial.二甲双胍治疗自闭症谱系障碍青少年使用非典型抗精神病药物引起的超重:一项随机临床试验。
JAMA Psychiatry. 2016 Sep 1;73(9):928-37. doi: 10.1001/jamapsychiatry.2016.1232.
5
Interprovincial Variation in Antipsychotic and Antidepressant Prescriptions Dispensed in the Canadian Pediatric Population.加拿大儿科人群中抗精神病药和抗抑郁药处方的省际差异。
Can J Psychiatry. 2016 Dec;61(12):758-765. doi: 10.1177/0706743716649190. Epub 2016 Jul 10.
6
Increased Risk of Obesity and Metabolic Dysregulation Following 12 Months of Second-Generation Antipsychotic Treatment in Children: A Prospective Cohort Study.儿童接受第二代抗精神病药物治疗12个月后肥胖和代谢失调风险增加:一项前瞻性队列研究
Can J Psychiatry. 2015 Oct;60(10):441-50. doi: 10.1177/070674371506001005.
7
Treating rural paediatric obesity through telemedicine vs. telephone: Outcomes from a cluster randomized controlled trial.通过远程医疗与电话治疗农村儿童肥胖症:一项整群随机对照试验的结果
J Telemed Telecare. 2016 Mar;22(2):86-95. doi: 10.1177/1357633X15586642. Epub 2015 May 29.
8
Antipsychotic use in children and adolescents: a 1-year follow-up study.儿童和青少年使用抗精神病药物:一项为期1年的随访研究。
J Clin Psychopharmacol. 2014 Oct;34(5):613-9. doi: 10.1097/JCP.0000000000000190.
9
Antipsychotics and the risk of type 2 diabetes mellitus in children and youth.抗精神病药与儿童和青少年 2 型糖尿病风险。
JAMA Psychiatry. 2013 Oct;70(10):1067-75. doi: 10.1001/jamapsychiatry.2013.2053.
10
Health Information Preference among Youth and Caregivers related to Second-Generation Antipsychotic Treatment.青少年及照顾者对第二代抗精神病药物治疗的健康信息偏好
J Can Acad Child Adolesc Psychiatry. 2012 Nov;21(4):302-9.